MedEye has secured a significant investment from ECFG and is partnering with Zuyderland Hospital in the Netherlands to implement its medication monitoring technology, aimed at reducing medication errors and enhancing patient safety.
Target Information
MedEye, founded in 2010, is an innovative company specializing in medication monitoring solutions for healthcare institutions. The company aims to mitigate the serious issue of medication errors that affect hospitals worldwide. MedEye utilizes advanced optical scanning technology to identify and verify medication types, significantly enhancing the safety of medication administration. This latest collaboration marks the largest implementation of MedEye’s technology to date, not only in terms of user count but also regarding the comprehensive utilization of its capabilities.
In this new deployment at Zuyderland Hospital in the Netherlands, MedEye’s solutions will assist nurses in verifying various forms of medications, including tablets, capsules, and injectable drugs. Additionally, the platform will automatically adjust dosage settings, which will save nursing staff time and help prevent input errors, thereby reinforcing overall patient safety.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Netherlands
The healthcare sector in the Netherlands is known for its high standards and accessibility, providing comprehensive medical services to the population. With over 17 million residents, the country emphasizes quality
Similar Deals
LUMO Labs and Graduate Entrepreneur → Surgical Reality
2025
ECFG
invested in
MedEye
in 2024
in a Other VC deal